A fair growth of 5.94% in the revenue at Rs. 791.32 millions was reported in the September 2022 quarter as compared to Rs. 746.96 millions during year-ago period.Good  Net Profit growth of 37.32% reported above the corresponding previous quarter figure of Rs. 95.13 millions to Rs. 130.63 millioins.Operating profit for the quarter ended September 2022 rose to 258.93 millions as compared to 197.58 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 791.32 746.96 5.94 1578.16 1357.01 16.30 2759.80 2090.51 32.02
Other Income 7.71 1.30 493.08 16.71 3.11 437.30 14.54 8.10 79.51
PBIDT 258.93 197.58 31.05 506.39 366.26 38.26 812.26 535.01 51.82
Interest 7.99 2.42 230.17 17.43 6.74 158.61 14.96 21.67 -30.96
PBDT 250.94 182.92 37.19 488.96 347.28 40.80 785.06 513.34 52.93
Depreciation 75.32 54.80 37.45 147.39 109.73 34.32 231.58 229.37 0.96
PBT 175.62 128.12 37.07 341.57 237.55 43.79 553.48 283.97 94.91
TAX 44.99 32.99 36.37 90.64 61.37 47.69 142.90 71.37 100.22
Deferred Tax -9.14 -6.93 31.89 -14.80 -12.39 19.45 -10.33 -4.89 111.25
PAT 130.63 95.13 37.32 250.93 176.18 42.43 410.58 212.60 93.12
Equity 44.22 44.22 0.00 44.22 44.22 0.00 44.22 44.22 0.00
PBIDTM(%) 32.72 26.45 23.70 32.09 26.99 18.89 29.43 25.59 15.00

Vimta Labs Share Price

1021.10 -66.60 (-6.12%)
28-Apr-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.80
Dr. Reddys Lab 1202.65
Cipla 1554.25
Lupin 2101.75
Zydus Lifesciences 884.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...